The QualityStocks Daily Friday, May 17th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (ROKK) +44.00%

StockMarketWatch (OTLK) +37.25%

CannabisNewsWire (DVLP) +34.12%

The QualityStocks Daily Stock List

Cuentas, Inc. (CUEN)

Financial Content, PR Newswire, Stockhouse, Wallet Investor, GuruFocus, InvestorsHub, and Simply Wall St reported earlier on Cuentas, Inc. (CUEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cuentas, Inc. is a foremost FinTech company serving the Latino and Hispanic underbanked and un-bankable market. The Company's services include, but are not limited to, mobile banking, online banking, prepaid debit, bill pay, ACH and mobile deposits, cash remittance, peer to peer money transfer, and bank accounts to customers who formerly could not obtain bank accounts. OTCQB-listed, Cuentas is headquartered in Miami, Florida.

The Company offers FINTECH services for 70-plus million underbanked Resident-Americans. Cuentas' banking, mobile wallet, bill pay, gift cards, pre-paid point of purchase credit, telecom and online services are in high-demand in its target markets. The Company built a portfolio in numerous fintech verticals to meet the highest-volume services needed by the underbanked US-Latino population.

The proprietary Cuentas General Purpose Reloadable (GPR) Card provides holders with digital wallets, discounts for purchases at major physical and online retailers, free telecom services, and the ability to purchase digital content. This card will be available in greater than 31,000 bodegas and more than 500,000 retailers. Bodegas are usually single owner markets, gas stations and local stores, which serve many immigrant and urban neighborhoods.

Cuentas signed a Letter of Intent (LOI) with Facio Ltd, an Israel financial technology (FinTech) company. Facio has developed inventive artificial intelligence (AI) and big data technologies to deliver digital banking services autonomously, without human intervention. This cooperation will enable Cuentas users to buy major brand digital content, products and services at a discounted price within an advanced and personalized Mobile App experience that combines traditional banking services with new unique services. Cuentas will enable its users to pay using Facio's innovative point of sale directly from its customer's mobile phone using Facio's Tap-to-pay NFC or QR technology.

Cuentas is now selling Sony PlayStation, Microsoft Xbox Live and Nexon Karma digital content at its more than 31,600 locations in the United States. The Company has now integrated its digital content system with the www.black011.com site to sell prepaid digital products including, but not limited to Sony PlayStation, Microsoft Xbox and Nexon Karma prepaid gaming products via the SDI Next distribution network of more than 31,600 "bodega" retailers.

Cuentas, Inc. (CUEN), closed Thursday's trading session at $3.10, up 11.11%, on 916 volume with 8 trades. The average volume for the last 3 months is 396 and the stock's 52-week low/high is $1.05/$7.50.

chart

Drone Delivery Canada Corp. (TAKOF)

Streetwise Reports, Play Stocks, Epstein Research, TipRanks, Marketbeat, Midas Letter, Wallet Investor, Market Screener, Stockwatch, Advice for Investors, Profit Confidential, GuruFocus, Barchart, and Stockhouse reported previously on Drone Delivery Canada Corp. (TAKOF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Drone Delivery Canada Corp. is a drone technology company headquartered in Vaughan, Ontario. It focuses on the design, development and implementation of its proprietary logistics software platform utilizing drones. The Company's vision is to become a key player in the Drone Delivery industry through commercializing its technology to create new and unique logistics platforms for retailers and government agencies. Drone Delivery Canada's shares trade on the OTC Markets Group's OTCQB.

The Company's group comprises highly experienced technology professionals who have successfully built, owned and operated technology ventures in the Canadian market. Drone Delivery Canada is utilizing state-of-the-art technology and materials to develop its next generation logistics platform. The Company's designs are patent pending.

Drone Delivery Canada's research and development (R&D) group is integrating next generation Super Materials into its delivery drone designs. This includes Graphene and Carbon Fiber. The Company's prototyping and design platform also uses 3D Printing systems to accelerate concept design.

Drone Delivery Canada's flight systems cover manifold levels of security, redundancy and resiliency. Employing industry leading software, customization, and patent pending architecture, the Company has a group of applications, which come together under an umbrella to provide a comprehensive solution for the delivery industry.

The flight systems include all aspects of a UAV from the operational component. They also integrate the logistics integration. The operational platform includes full operational guidance, route planning, geo-fencing, alerts, telemetry, maintenance, logs, and full Preventative Maintenance scheduling and tracking.

Recently, Drone Delivery Canada announced, as it moves to commercial operations and revenue generation in 2019 in remote Canada and rural Canadian communities, that it will also be immediately pursuing eight additional business verticals where it sees significant growth opportunities. This year, the Company will be pursuing opportunities in eight other additional verticals that include Healthcare, Pharmaceuticals, Oil & Gas, Mining, Agriculture, Forestry, Construction and Courier Companies.

Drone Delivery Canada Corp. (TAKOF), closed Thursday's trading session at $2.95, up 8.46%, on 146,294 volume with 256 trades. The average volume for the last 3 months is 197,950 and the stock's 52-week low/high is $1.10/$15.01.

chart

Frélii, Inc. (FRLI)

Simply Wall St, Last10k, Investors Hangout, The Health Investor, DNA Investor Alerts, Trade Ideas, Current Charts, Market Screener, Business Wire, Wallet Investor, Investing Online, Seeking Alpha, MarketWatch, and Northfield Review reported previously on Frélii, Inc. (FRLI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Frélii, Inc. is a medical technology company listed on the OTCQB. It uses gene sequencing and artificial intelligence (AI) to determine risk and lifestyle modifications. Its technology analyzes the most comprehensive markers (60,000,000-plus) on the market to date. The Company was formerly known as Vican Resources, Inc. It changed its corporate name to Frélii, Inc. in March 2018. Frélii has its head office in Lehi, Utah.

In essence, Frélii is data mining DNA. It takes advantage of the big data of DNA to improve health and wellness and enhance the human experience. The design of its technology has been to allow assessment and sequencing, for reporting needs into different life science environments.

Frélii's technology generates accurate and significantly valuable insight into DNA. The Company says that it opens opportunities never realized in health care, precision medicine, insurance, corporate wellness and personal health and risk identification.

Frélii takes a unique approach to health through taking advantage of its highly advanced AI to deliver more holistic DNA analysis. This is to provide precision regarding what medical professionals and individuals need concerning correct drugs, dosing, diet and interventions.

The Company continues to develop and grow its patented AI technology, leveraged base code and large data sets gathered from public and private partnerships. Its predictive capacity with its precision medicine and health and wellness AI has increased from 84 percent to 98.5 percent.

In addition, the flagship high-efficiency Genetic Sequencing and analysis using Frélii's proprietary technology has increased to greater than 99 percent and 99.999 percent accuracy on whole genome and exome sequencing, respectively. Frélii announced this past March that it signed a Memorandum of Understanding (MOU) with NewPath Health Care Solutions, Inc. of Ontario, Canada; Mercator Biologic, Inc. of Centerville, Utah; and True DNA Story, LLC of Centerville, Utah. The purpose of the MOU is to strategically explore the complete capabilities of each company to identify synergies and opportunities in order to leverage the innovative skillsets of the collective.

At the beginning of May, Frélii announced that it signed a contract and licensing agreement with Optivida Health. Optivida will leverage Frelii's proprietary DNA Kit Packages™ to ensure Optivida customers can realize the optimal benefits of which specific Optivida products best suit their unique DNA profile. Optivida is one of the nation's leaders in advanced hemp extract for the consumer market.

Mr. Ian Jenkins, Frélii's Chief Executive Officer, said, "Historically, the only approach to using hemp extract, hemp oil, CBD and other cannabinoid products effectively has been through trial and error. Now, through the power of Frelii's proprietary DNA Kit Packages, Optivida customers can have their whole DNA sequenced and analyzed, whereby they will be given the ability to know what hemp, CBD and other products are most appropriate and what precision dose will work most effectively for their own specific needs."

Frélii, Inc. (FRLI), closed Thursday's trading session at $1.10, up 7.84%, on 13,858 volume with 20 trades. The average volume for the last 3 months is 2,078 and the stock's 52-week low/high is $0.125/$1.84.

chart

Leafbuyer Technologies, Inc. (LBUY)

Zacks, Micro Small Cap, Micro Cap Daily, TipRanks, Wallet Investor, Marijuana Stocks, Daily Marijuana Observer, Pot Stock News, New Cannabis Ventures, Proactive Investors, Market News Updates, OTC Markets, 4-Traders, Stockhouse, MarketWatch, Insider Financial, InvestorsHub, Simply Wall St, Stockwatch, and GuruFocus reported previously on Leafbuyer Technologies, Inc. (LBUY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2012, Leafbuyer Technologies, Inc. is a foremost cannabis marketing and technology platform. Leafbuyer.com is one of the most complete online sources for cannabis deals and information. The Company works alongside cannabis businesses to showcase their innovative products and build a network of loyal patrons. OTCQB-listed, Leafbuyer Technologies has its corporate headquarters in Greenwood Village, Colorado.

Leafbuyer Technologies' online network reaches millions of marijuana consumers monthly. Leafbuyer is the official cannabis deals platform of LA Weekly, Voice Media Group, Dope Media, Grasscity, and The Stranger. The Company is the largest cannabis deals network in the nation.

Leafbuyer partners with cannabis dispensaries and product companies across the U.S. to bring the best legal cannabis deals to consumers. The Company's business plan includes expanding into every State in the U.S.

Last month, Leafbuyer Technologies announced the launch of its innovative delivery technology to complement its mobile application. The preliminary beta launch in April included dispensaries in California and other States with legal cannabis delivery laws.

Dispensaries in States such as California, Arizona, Nevada, and Washington can now add delivery to their list of offerings via the Greenlight mobile application. Consumers can place an order for cannabis products to be delivered from a participating dispensary much the same way a person can order a pizza by way of a mobile application.

Mr. Kurt Rossner, Leafbuyer Technologies' Chief Executive Officer, said, "The addition of this new technology will allow us to monetize our consumer base through a fee generated from each transaction. We'll be able to penetrate thousands of new dispensaries and delivery companies in legal markets by offering this delivery solution. Leafbuyer will not physically deliver the products, rather we will hand off the 'last mile' to our delivery and dispensary partners."

Yesterday, Leafbuyer Technologies announced its quarterly sales increased 70 percent in the quarter ending March 31, 2019. The growth reflects the revenue booked in the quarter in comparison to the same quarter of the prior year. The Company's 70 percent year-over-year growth rate is more than double the industry's national average of 26.7 percent, according to Arcview Market Research and BDS Analytics.

Leafbuyer Technologies, Inc. (LBUY), closed Thursday's trading session at $2.86, up 5.93%, on 193,499 volume with 155 trades. The average volume for the last 3 months is 21,337 and the stock's 52-week low/high is $1.889/$4.23.

chart

Pacific Green Technologies, Inc. (PGTK)

Micro Cap Spot, The Headhunters, Last10k, Trading View, Marketbeat, InvestorsHub, Wallet Investor, Stockhouse, Simply Wall St, 4-Traders, Stockwatch, Market Exclusive, GlobeNewswire, Investors Hangout, MarketWatch, Dividend Investor, Stockopedia, and Market Screener reported earlier on Pacific Green Technologies, Inc. (PGTK), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Pacific Green Technologies, Inc. is the owner of the ENVI-Marine™ and ENVI-Clean (TME) Exhaust Gas Scrubbing Systems. The Company has developed a portfolio of patented, emission control technologies. These remove pollutants from marine engine, power plant and waste incinerator exhaust streams to meet increasingly stringent environmental standards. Its solutions utilize its patented "Turbo Head Technology™". Established in 2011, Pacific Green Technologies is headquartered in San Jose, California.

The "Turbo Head Technology™" enables a more thorough mixing of exhaust gases and a chosen reagent solution, which delivers more effective contaminant removal in a system that is smaller and more efficient to build and operate. Pacific Green Technologies uses a global network of experts in the field of emissions control, with the technology proving to be very effective and cost efficient.

Moreover, the Company created a strategic joint venture (JV) with PowerChina SPEM, a unit of China's largest engineering, procurement, and construction firm. This JV is to support the manufacture, design, and installation of its solutions on a worldwide scale, while also serving as an in-country sales agent for commercial opportunities in mainland China. In August 2017, Pacific Green Technologies announced the signing of a Memorandum of Understanding (MOU) with PowerChina SPEM Co. Limited to incorporate a new company whereby Pacific Green Technologies own 50.1 percent and PowerChina SPEM 49.9 percent.

ENVI-Marine™ is a new generation of scrubbing technology. It has a simple patented design, no moving parts or media, and industry leading efficiency. In addition, the Company's ENVI-Clean (TME) captures sulphur at the source before it pollutes the atmosphere.

In December 2018, Pacific Green Technologies announced that its wholly-owned subsidiary, Pacific Green Marine Technologies, Inc. (PGMT), executed an agreement to manufacture its System for 52 vessels owned or managed by Scorpio Tankers, Inc. (STNG). The Agreements provide for 42 vessels in 2019 and 10 vessels in 2020.

This past February, Pacific Green Technologies announced the appointment of Mr. Richard Oliver as Chief Financial Officer, a new position at Pacific Green, effective May 24, 2019. Before the start of Mr. Oliver's employment, the Company's Chief Executive Officer, Mr. Neil Carmichael, has served as Principal Financial Officer and Principal Accounting Officer, which roles will be assumed by Mr. Oliver. He is a finance professional with 33 years' of financial accounting, auditing and management experience in manufacturing, fabrication and inventory management.

Pacific Green Technologies, Inc. (PGTK), closed Thursday's trading session at $2.03967, up 1.98%, on 140,856 volume with 221 trades. The average volume for the last 3 months is 460,227 and the stock's 52-week low/high is $0.259/$2.70.

chart

Rokk3r, Inc. (ROKK)

Invest Tribune, Dividend Investor, Market Screener, Investors Hangout, Stockopedia, Wallet Investor, Barchart, Stockhouse, Simply Wall St, MarketWatch, InvestorsHub, Stockwatch, Street Insider, and PR Newswire reported earlier on Rokk3r, Inc. (ROKK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rokk3r, Inc. is an international idea-to-exit company builder listed on the OTC Markets. The design of the Company's services are to leverage exponential technologies to quickly accelerate and shape industries. Its ecosystem approach aims to lessen friction and streamline execution through taking advantage of talent, shared services, experience, and networks. Rokk3r has its corporate headquarters in Miami, Florida.

The Company provides a set of services that is a hybrid network of human and machine intelligence systems, seeking to enable early stage start-up technology companies and existing businesses to develop new products and businesses in a frictionless, accelerated and complete way. The exponential technologies include artificial intelligence (AI), augmented and virtual reality (AR, VR), blockchain (decentralized ledger technologies), data science, digital biology and biotech, machine learning, nanotech, robotics and sensors.

Rokk3r works to optimize rates of success in company building and product development through offering a wider range of essential services in one place. From business diagnosis to strategy design, execution and funding, the Company helps organizations and ventures augment and transform exponentially.

Regarding its Global Idea-to-Exit Ecosystem, Rokk3r de-risks and democratizes company building via a blockchain based platform that leverages a hybrid of human and machine intelligence. The Company is unleashing the next generation of worldwide entrepreneurship through providing access to education, idea validation, team creation and experts to crowd build successful ventures.

Rokk3r is the newest affiliate of Techstars, the global network that helps entrepreneurs succeed. The entities' affiliate relationship grants Rokk3r-referred start-ups, including Rokk3r's portfolio of over 40 companies, and expedited entry to Techstars' accelerator network, among other benefits.

Techstars founders and their teams connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporate partners who will help their companies grow. Techstars operates three divisions. These are Techstars Startup Programs, Techstars Mentorship-Driven Accelerator Programs, and Techstars Corporate Innovation Partnerships.

                   

Rokk3r, Inc. (ROKK), closed Thursday's trading session at $4.34, up 10.71%, on 500 volume with 4 trades. The average volume for the last 3 months is 581 and the stock's 52-week low/high is $3.13/$5.50.

chart

Aleafia Health, Inc. (ALEAF)

CannabisMarketCap, SmallCapPower, The Cannabis Investor, Micro Small Cap, Insider Financial, Pot Stock News, New Cannabis Ventures, Midas Letter, Simply Wall St, Trading View, Stockwatch, Proactive Investors, Wallet Investor, Market Screener, InvestorsHub, Stockhouse, and Technical420 reported previously on Aleafia Health, Inc. (ALEAF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Aleafia Health, Inc. is a foremost, vertically integrated cannabis health and wellness company based in Toronto, Ontario. It has four main business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements. The Company operates the largest national network of medical cannabis clinics and education centers staffed by MDs, nurse practitioners and educators.

Aleafia Health's shares trade on the OTC Markets Group's OTCQX. The Company was named the 2019 top performing company of the year by the TSX Venture Exchange before graduation to the TSX.

Aleafia Health owns three major cannabis product and cultivation facilities. Two are licensed and operational. The Company produces a varied portfolio of commercially proven, high-margin derivative products. This portfolio includes oils, capsules and sprays. Aleafia maintains a medical cannabis dataset with more than 10 million data points to inform proprietary illness-specific product development and treatment best practices.

Earlier in May, Aleafia Health announced it is entering the German medical cannabis market through its joint venture (JV) with German pharmaceutical wholesaler Acnos Pharma GmbH. The JV entity will purchase Aleafia Health branded cannabis oils for distribution to German pharmacies and for clinical trial usage. Aleafia Health's wholly-owned subsidiary Emblem Cannabis Corp. is the majority shareholder of the JV with 60 per cent ownership with Acnos Pharma owning the remaining 40 per cent.

Additionally, this month, Aleafia Health announced it completed the largest adult-use cannabis order in its history on May 9, 2019. The Order was scheduled to depart from Aleafia'a facility on May 9, with delivery to a Canadian provincial government for distribution to online and retail consumers. It will contain Aleafia Health's branded Symbl oils, oral sprays, as well as dried flower products.

Aleafia Health announced that it received a status update letter from Health Canada indicating that the Company's Cultivation Licence application for its Niagara Greenhouse facility passed a high-level review and that Health Canada has no concerns at this point. Passing this mandatory review is an important requirement as outlined by the new licensing guidelines announced by Health Canada on May 8, 2019. Aleafia Health also reported that its Licence Amendment application for the Port Perry Outdoor Grow expansion is now officially under review by Health Canada.

Aleafia Health, Inc. (ALEAF), closed Wednesday's trading session at $0.7175, down 4.33%, on 63,117 volume with 50 trades. The average volume for the last 3 months is 61,004 and the stock's 52-week low/high is $0.704/$2.69.

chart

MedMen Enterprises, Inc. (MMNFF)

Insider Financial, OTC Stock Picks, New Cannabis Ventures, OTC Markets, Penny Stock Hub, GuruFocus, OTC Stock Watch, Stockhouse, 4-Traders, Investing News, The Street, Wallmine, TradingView, Barchart, Stockwatch, Morningstar, MarketWatch, Daily Marijuana Observer, and Investors Hangout reported previously on MedMen Enterprises, Inc. (MMNFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MedMen Enterprises, Inc. brings expertise and capital to the cannabis industry. The Company is one of the nation's largest financial supporters of progressive marijuana laws. MedMen Enterprises owns and operates facilities covering the whole vertical from cultivation to manufacturing to retail in key states, including California, Nevada, and New York. MedMen Enterprises is headquartered in Culver City, California and the Company lists on the OTC Markets Group's OTCQX.

MedMen Enterprises manages class leading retail stores that sell marijuana and marijuana products. The Company operates a number of dispensaries in the most strategic markets in the nation. It has a fast-growing footprint that includes expansion plans in other important States and also Canada. At present, MedMen has flagship stores in Los Angeles, Las Vegas and New York.

The Company has added ground cannabis flower to its product offerings in the State of New York. At present, its stores in New York offer vaporizer pens, tinctures and gel caps in five different formulations. The addition of ground flower will give its New York medical marijuana patients more product choices in the State's fast developing marketplace.

MedMen Enterprises earlier announced its expansion into Florida via a proposed acquisition of dispensary and cultivation assets from Treadwell Simpson Partnership and affiliates. MedMen secured prime retail locations with long term leases in Ft. Lauderdale, Miami Beach, West Palm Beach, St. Petersburg and Key West.

MedMen Enterprises also acquired a dispensary and cultivation license and related assets from Florida based Treadwell Simpson Partnership and affiliates (Treadwell Nursery). The License permits MedMen to open 30 (and up to 35 if certain conditions are met) medical marijuana dispensaries in Florida and to conduct cultivation, delivery and manufacturing operations in the State.

In February, MedMen Enterprises announced that it closed its earlier announced acquisition of Kannaboost Technology Inc. and CSI Solutions LLC, collectively referred to as "Level Up," two vertically-integrated operations in the State of Arizona. The acquisition includes retail locations in Scottsdale and Tempe, and 25,000 square feet of cultivation and production capacity in Tempe and Phoenix. Moreover, the acquisition includes a 40 percent stake in top-selling brand K.I.N.D. Concentrates that is presently distributed in more than 90 percent of the dispensaries in Arizona.

In March, MedMen Enterprises announced that it completed the sale of two properties to Treehouse Real Estate Investment Trust, Inc. with gross proceeds of roughly $33.5 million and net proceeds of about $30.6 million after repayment of debt. The properties consist of a retail storefront in Las Vegas, Nevada and a cultivation, manufacturing and production facility in Desert Hot Springs, California.

Mr. Adam Bierman, MedMen Enterprises' Chief Executive Officer and Co-Founder, said, "This is our second transaction with Treehouse and we've now freed up nearly $49 million to invest directly into our growth initiatives."

MedMen Enterprises, Inc. (MMNFF), closed Thursday's trading session at $1.90, up 2.70%, on 1,662 volume with 4 trades. The average volume for the last 3 months is 1,391 and the stock's 52-week low/high is $0.509/$4.00.

chart

Aspen Group, Inc. (ASPU)

Stock Twits, Tip Ranks, Greenbackers, Simply Wall St, InvestorsHub, Taglich Brothers, Seeking Alpha, TheMicrocapNews, Zacks, Stock News Now, Smarter Analyst, GlobeNewswire, RedChip, YCharts, Barchart, GuruFocus, and MarketWatch reported earlier on Aspen Group, Inc. (ASPU), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Aspen Group, Inc. is a for-profit post-secondary education company - an education technology holding enterprise. It owns two accredited universities. These are Aspen University and United States University. The mission of Aspen University is to offer any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education to attain sustainable economic and social benefits for themselves and their families. Aspen Group is headquartered in New York, New York.

Aspen University's dedication is to provide the highest quality education experiences taught by top-tier faculty. Greater than 50 percent of Aspen University's faculty hold doctoral degrees. Degrees offered by Aspen University include Associates, Bachelor's, Master's, Doctoral, and Certificates. Aspen University has its School of Professional Studies, School of Nursing, School of Education, School of Management, School of Information Technology, and College of Arts and Sciences.

In 1997, United States University commenced its institutional history as InterAmerican College in National City, California. In 2010, the school was renamed United States University. United States University has its campus in the heart of San Diego, California. The University is regionally accredited by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges. United States University offers Bachelor and Master level degree programs in nursing, education, health science, and business & management.

In March, Aspen Group announced financial results for its 2019 fiscal Q3 ended January 31, 2019, highlighted by record Revenue of $8,494,627. This represents an increase of 49 percent versus Q3 of fiscal year 2018. Gross Profit totaled $4,221,939 or a 50 percent margin. This represents a 46 percent increase versus the previous fiscal year Q3.

Net Loss applicable to Shareholders was ($2,355,940), versus a Net Loss of ($2,147,945) in the prior fiscal year Q3. Diluted Net Loss per Share was $(0.13), versus a loss of $(0.15) in the prior fiscal year Q3.

Of note is that Aspen Group acquired United States University (USU) and all its operating expenses on December 1, 2017. USU Revenues contributed roughly 21 percent of the quarterly revenues for Aspen Group versus 19 percent in the prior quarter.

Also, in March, Aspen Group announced the WASC Senior College and University Commission's (WSCUC) formal acceptance of United States University's Special Visit Review that resulted in confirmation of the University's accreditation. At its February 22, 2019 meeting, WSCUC provided formal notification of its acceptance of the institutional report as a result of its Special Visit that took place on November 28-30, 2018.

Aspen Group, Inc. (ASPU), closed Thursday's trading session at $1.0056, up 3.19%, on 30,516 volume with 32 trades. The average volume for the last 3 months is 19,202 and the stock's 52-week low/high is $0.55/$2.14.

chart

Emerald Health Therapeutics, Inc. (EMHTF)

Green Leaf Pot Stocks, Proactive Investors, Cannabis News Wire, GuruFocus, Cannabindex, InvestorsHub, Midas Letter, Profit Confidential, Financial Buzz, Pot Network, Stock News Now, Market Screener, Cannabis Stock Trades, Stockhouse, Barchart, Business Insider, Morningstar, MarketWatch, Insider Financial, Daily Marijuana Observer, Wallet Investor, and Technical420 reported earlier on Emerald Health Therapeutics, Inc. (EMHTF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Emerald Health Therapeutics, Inc. is a Canadian licensed producer of cannabis. Its team is highly experienced in life sciences, product development, large-scale agri-business, as well as marketing. The Company's focus is on developing proprietary, value-added cannabis products for medical and adult-use customers. Emerald Health Therapeutics is based in Victoria, British Columbia and the Company lists on the OTC Markets' OTCQX.

Emerald Health Therapeutics is essentially a vertically integrated, seed-to-sale business. It is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits through interacting with the human body's endocannabinoid system.

Emerald's emphasis is on enhancing health through cannabis science. The Company is a Licensed Producer under Canada's Access to Cannabis for Medical Purposes Regulations. Emerald produces and sells dried cannabis and cannabis oil for medical and recreational purposes.

Emerald Health Therapeutics announced this past January that it closed its 51:49 JV with Emerald Health Bioceuticals (EHB), named the above-mentioned Emerald Health Naturals (EHN). Emerald has invested $5,000,000 for 51 percent equity ownership of EHN. EHB has granted EHN the exclusive Canadian distribution rights to EHB's award-winning product line in exchange for 49 percent equity ownership of EHN. EHB's product line comprises nutritional supplements and these supplements use non-cannabis, non-psychoactive plant-based bioactive compounds to support the body's endocannabinoid system.

Recently, Emerald Health Therapeutics announced that its 50 percent-owned joint venture (JV) for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms Corp., received from Health Canada its seventh amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, British Columbia. The additional roughly 206,000 square feet of growing area in the fourth and final quadrant of the greenhouse brings Pure Sunfarms' total licensed cannabis production area to about 1.03 million sq. ft. in 16 grow rooms. The expectation is that the newly licensed area will be fully planted by the end of this month.

Moreover, Emerald Health Therapeutics recently announced it fulfilled its initial purchase order of cannabis from Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (OCS). Dr. Avtar Dhillon, President and Executive Chairman of Emerald Health Therapeutics, said, "As we scale up production in our wholly-owned, premium indoor growing facility, Verdélite, and our large-scale, state-of-the-art joint venture greenhouse operation, Pure Sunfarms, we are consistently meeting our supply commitments of Emerald-branded adult-use cannabis in British Columbia and Newfoundland Labrador, and we are now prepared to provide the same service to the Ontario Cannabis Retail Corporation and other provinces."

Emerald Health Therapeutics, Inc. (EMHTF), closed Thursday's trading session at $1.60, up 17.65%, on 10,700 volume with 22 trades. The average volume for the last 3 months is 2,300 and the stock's 52-week low/high is $1.02/$2.75.

chart

Diego Pellicer Worldwide, Inc. (DPWW)

Business Insider, The Street, Barchart, 4-Traders, MarketWatch, InvestorsHub, Insider Financial, StockAnalyst24, Stockhouse, GlobeNewswire, Daily Marijuana Observer, Penny Stock Tweets, Barchart, Stock Invest, Seeking Alpha, Financial Content, and PR Newswire reported earlier on Diego Pellicer Worldwide, Inc. (DPWW), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Diego Pellicer Worldwide, Inc. is a real estate and consumer retail development company. It concentrates on developing the Company as the world's first "premium" marijuana brand. Its tenants are stand-alone, independent businesses and Diego Pellicer Worldwide has no ownership in them. OTCQB-listed, Diego Pellicer Worldwide has its corporate headquarters in Seattle, Washington.

The Company's initial revenues originate from leasing real estate and selling non-cannabis related products. Diego Pellicer does not grow or sell marijuana or marijuana infused products. It leases legally compliant locations for growing, retailing, or the medical dispensing of marijuana. 

The Company is where responsible marijuana connoisseurs and sommeliers assemble to explore the world of premium marijuana. Diego Pellicer is the international leader in property acquisitions and leasing in the developing cannabis space. Its initial focus is to acquire and develop legally compliant real estate locations for the purposes of leasing them to State licensed companies in the cannabis industry.

Diego Pellicer participates in the profit of café operations of non-infused products; participates in the profit of ancillary products, including branded apparel; and in some instances, it signs contracts with its tenants, with the right to acquire at its discretion. The Company has secured numerous premier locations in Colorado, Washington, and Oregon. Its first flagship store tenant, Diego Pellicer-Washington (3,000 sq. ft. space) passed its final inspection for retail marijuana sales and began operations in Q4 2016. This flagship store features high-end cannabis products and accessories.

Recently, Diego Pellicer Worldwide announced that Diego Pellicer - Colorado celebrated its second anniversary on Valentine's Day announcing record-breaking sales. Diego Pellicer Worldwide announced the Denver licensee's location reported a 111 percent year-over-year growth from January 2017 to January 2019.

Mr. Ron Throgmartin, Chief Executive Officer of Diego Pellicer Worldwide, said, "We congratulate Diego Pellicer – Colorado's team on its success. With our leadership, branding model and experience, we look forward to helping other retailers and operators experience such prosperity."

Diego Pellicer Worldwide, Inc. (DPWW), closed Thursday's trading session at $4.00, up 99.00%, on 585 volume with 5 trades. The average volume for the last 3 months is 237 and the stock's 52-week low/high is $1.00/$100.00.

chart

BioRestorative Therapies, Inc. (BRTX)

Simply Wall St, Capital Cube, Pink Investing, Proactive Investors, 4-Traders, Market Screener, MarketWatch, InvestorsHub, Barchart, Stockopedia, ProActive Capital, GuruFocus, Investor Ideas, Corporate Information, Streetwise Reports, Zacks, Stockhouse, and Marketbeat reported previously on BioRestorative Therapies, Inc. (BRTX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

BioRestorative Therapies, Inc. is a life sciences company focusing on adult stem cell-based therapies for various personal medical applications. The Company develops products and medical procedures utilizing cell and tissue protocols, primarily involving adult stem cells. OTCQB-listed, BioRestorative Therapies has its corporate, administrative, and laboratory operations in Melville, New York.

The Company's aim is to become a leader in providing medical procedures using cell and tissue protocols, chiefly involving adult stem cells (non-embryonic), and enabling patients to undergo minimally invasive cellular-based treatments. BioRestorative Therapies is developing a cell-based therapy to target obesity and metabolic disorders utilizing brown adipose (fat) derived stem cells to produce brown adipose tissue (BAT). The intention of BAT is to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans.

Bio Restorative's lead cell therapy candidate is BRTX 100. This product is formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. The Company's products and medical procedures include brtxDISC™ (Disc Implanted Stem Cells), its Disc/Spine Program, and ThermoStem®, its Metabolic Program.

brtxDISC™ is an investigational non-surgical treatment for bulging and herniated lumbar discs. brtxDISC™'s intention is for patients who have failed non-invasive procedures and face the prospect of surgery. ThermoStem® is a treatment using brown fat stem cells. ThermoStem® is under development for metabolic disorders, including diabetes and obesity.

BioRestorative Therapies is also the beneficiary of a patent granted for a licensed curved needle device (CND). The design of it is to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair.

Recently, BioRestorative Therapies announced the creation of a Disc Advisory Committee of its Scientific Advisory Board (SAB). Jason Lipetz, MD, a member of the Company's SAB headed by Dr. Wayne Marasco, will Chair the newly created Committee. Dr. Lipetz joined the SAB in October of 2018.

In addition to Wayne Olan MD, the Director of BioRestorative's Disc/Spine Regenerative Program, the SAB added Harvinder Sandhu, MD; Christopher Plastaras, MD; and Gerard A. Malanga, MD.

Wayne Marasco, MD, Ph.D., Chairman of the BioRestorative Therapies Scientific Advisory Board, said, "Dr. Jason Lipetz has recruited a prestigious team of spine experts. This SAB subcommittee will provide outstanding leadership and guidance to BRTX as we move toward initiation of our clinical trial for our lead BRTX-100 autologous stem cell product."

BioRestorative Therapies, Inc. (BRTX), closed Thursday's trading session at $0.7398, up 1.06%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 9,477 and the stock's 52-week low/high is $0.7106/$1.159.

chart

Liberated Syndication, Inc. (LSYN)

The Hot Penny Stocks, Market Exclusive, Stockflare, Penny Stock Hub, Tip Ranks, Trading View, Insider Mole, Promotion Stock Secrets, Dividend Investor, Wallet Investor, InvestorsHub, Stock Invest, Investors Hangout, Stockhouse, and Simply Wall St reported earlier on Liberated Syndication, Inc. (LSYN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Liberated Syndication, Inc. engages in the podcast hosting services business in the U.S. The Company previously went by the name Webmayhem, Inc. It changed its corporate name to Liberated Syndication, Inc. in August of 2016. Liberated Syndication has its corporate office in Pittsburgh, Pennsylvania. The Company lists on the OTC Markets Group's OTCQB.

Liberated Syndication has its OnPublish – Multiple Destination Publishing. Its services provide independent podcasters tools to create a first-rate podcast and get that podcast into as many platforms as possible. The Company is the largest leading podcast network. It provides podcast hosting services for producers of podcasting content; independent podcasters' tools to publish content; and also mobile applications (apps) for podcasts.

Liberated Syndication's publishing platform integrates content delivery to social media and blog platforms through OnPublish, the Company's Facebook App and HTML5 player. OnPublish incorporates publishing to Facebook, Twitter, WordPress and Blogger right from Liberated Syndication (Libsyn).

Concerning Podcast Hosting Services, hosting is optimized for audio and video podcast distribution. The network is speedy and reliable and unmetered bandwidth and flexible storage space increases over time. Furthermore, the Libsyn custom smartphone app for podcasters involves audiences beyond one's regular audio or video episodes. Four different kinds of content are accepted by the app (audio, video, PDF and text).  All in one place, a user can offer their audience extras, blog posts, transcripts, and more.

The Company also offers advertisement insertion on certain of the producers' content. Regarding MyLibsyn – Premium Content, it is a comprehensive subscription management service. The MyLibsyn offering includes a custom premium page and mobile apps available across four markets. One's subscribers sign up and create one username and password. They can access their subscription across all available apps and one's branded premium page.

Liberated Syndication also has its LibsynPRO – Enterprise Solutions. This is for professional media producers and corporate customers. LibsynPRO features podcast network tools. It is a turn-key podcast network solution. It allows for as many different shows and episodes as needed.

Recently, Liberated Syndication announced Revenue of $22,010,132 for the full year 2018. This represents an increase of 108 percent over full year 2017 Revenue of $10,584,219. This Revenue was propelled by the Revenue generated from the Company's acquisition of Pair Networks and also from 30 percent growth in Libsyn Podcasting (Libsyn4) Revenue.

Mr. Chris Spencer, Liberated Syndication Chief Executive Officer, said, "Management expects podcasts to continue to grow in popularity as they have become an integral part of brand strategy along with websites, blogs and social media outlets. We expect 2019 to be a very good year for Liberated Syndication's podcast hosting business and with the changes we've incorporated at Pair Networks, we anticipate strong growth across all aspects of our business."

Liberated Syndication, Inc. (LSYN), closed Thursday's trading session at $0.03, up 19.52%, on 27,811 volume with 10 trades. The average volume for the last 3 months is 119,290 and the stock's 52-week low/high is $0.0104/$0.082.

chart

OriginClear, Inc. (OCLN)

Penny Stock Tweets, Trading View, Marketbeat, Barchart, MicroCap Daily, Emerging Growth, Chart Diligence, Dividend Investor, Simply Wall St, Capital Cube, InvestorsHub, The Street, Stockwatch, YCharts, Market Screener, Infront Analytics, MarketWatch, Insider Financial, and Wallet Investor reported previously on OriginClear, Inc. (OCLN),  and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OriginClear, Inc. is  a foremost provider of water treatment solutions. Additionally, it is the developer of an inventive water cleanup technology. Via its wholly-owned subsidiaries, OriginClear provides systems and services to treat water in a wide array of industries. These include  municipal, pharmaceutical, semiconductors, industrial, and  oil & gas.

The Company has its wholly-owned subsidiary, Progressive Water Treatment (PWT) of Dallas, Texas. It also has its new operating division, Modular Water Systems (MWS), launched in late June 2018. OriginClear has its head office in Los Angeles, California. The Company lists on the OTC Markets.

OriginClear invented Electro Water Separation™. This is a leading-edge high-speed water cleanup technology employing multi-stage electrolysis that the Company licenses globally to water treatment equipment manufacturers. OriginClear's mission is to develop Electro Water Separation™ with Advanced Oxidation™ (EWS:AOx™) and accomplish its full recognition as a worldwide industry standard in treating increasingly complex wastewater treatment challenges.

OriginClear has completed development and testing of AOxPlus™. This is a method to produce hydroxyl radicals in large quantities to treat highly contaminated wastewater.   

Electro Water Separation™ (EWS) is a highly scalable, continuous process. It uses electricity in small, programmed doses to gather up oils and suspended solids. Moreover, through Advanced Oxidation or AOx,  it removes  fine, micron-sized suspended solids, and dissolved contaminants, including ammonia.

OriginClear previously engaged London-based The Coin Lab to assist in developing a blockchain protocol, with industry participation, called WaterChain™. The Coin Lab's task is to develop a blueprint and process for executing on the technology strategy of placing the water industry on a blockchain protocol with a water transactional token, or coin.

In February, OriginClear reported that in January, its Progressive Water Treatment subsidiary almost tripled its rate of bookings, totaling approximately $900,000 in Purchase Orders (POs) for January. The largest win was for a power plant, in competition against five major equipment manufacturers.

Riggs Eckelberry, OriginClear's Chief Executive Officer, said, "I am ecstatic as well as the rest of the OriginClear team with the early results from Marc Stevens, Mike Jenkins and the entire PWT team. They won that large contract against fierce competition because of diversity, attention to detail, and a successful track record. This increase in bookings is a great start for the new year!"

OriginClear, Inc. (OCLN), closed Thursday's trading session at $0.484, up 21.00%, on 213,180 volume with 118 trades. The average volume for the last 3 months is 43,173 and the stock's 52-week low/high is $0.2175/$0.836.

chart

The QualityStocks Company Corner

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGRMF).

Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced that the presentations from the Cannastocks2019 Q1 Virtual lnvestor Conference are available for on-demand viewing. Among the companies featured is Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF). Also today, the company was pleased to announce that its common shares will commence trading on the Nasdaq Global Select Market under the symbol "OGI" on Tuesday May 21, 2019. Additionally, the company was highlighted today in a publication from Financialnewsmedia.com, examining how after years of prohibition, cannabis is taking center stage as legalization rolls across the U.S. and most of the global community.

Organigram Holdings Inc. (TSX.V: OGI) (OTC: OGRMF) is the parent company of Organigram Inc., an original and leading Canadian licensed producer ("LP") of premium, quality cannabis and extract-based products. Founded in 2013 and headquartered in Moncton, New Brunswick, Canada, Organigram is focused on producing the highest-quality indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company's global footprint.?

Organigram delivers industry-leading yields and maximizes cannabis production at the lowest cultivation cost among other Canadian licensed producers. Organigram's high-tech facilities utilize an efficient, state-of-the-art mechanical room that includes both ethanol and CO2 extraction methods.

The company first began as a medical cannabis provider producing 5,000 kg/year (11,000 lbs) of 100 percent organic cannabis grown in pre-fabricated grow pods. Within two years, Organigram increased production to 36,000 kg/year (70,000 lbs) by utilizing an inventive, indoor 3-tier growing system. The company's pharmaceutical grade, state-of-the-art facility currently houses over 45,000 flowering plants growing at any one time.

Organigram's head office, production facility and research & development program are located on the company's 14-acre campus that houses several buildings and a 40-megawatt substation. Leading the way with a proprietary software system that acts as the nervous system of the entire organization, Organigram's team employs a data-driven decision-making process that ensures efficiency and top yields. Numerous design and automation improvements include an ergonomically friendly grow room design, automatic potting machines and automated packaging lines, and larger propagation rooms with advanced environmental systems.

Organigram's fully funded Phase 4 expansion is underway which, when complete by fall of 2019, will bring production capacity of high-quality premium cannabis to 113,000 kg/year (249,000 lbs). The Company has also invested in Hyasynth, a Montreal-based biotechnology company and leader in the field of cannabinoid science and biosynthesis. Hyasynth has developed a disruptive technology using patented enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation.

Organigram expects to double its workforce within the year to accommodate increasing growth as the facility expands to 480,000 square feet of production space at full buildout. In September 2017, Organigram signed the first ever recreational cannabis supply agreement in Canada with the Province of New Brunswick. Since then, Organigram has signed similar supply agreements with nine out of 10 provinces, has already exported product out of Canada, and is currently working with German medical cannabis provider, Alpha-cannabis, and Serbia-based Eviana Health Corp. (CSE: EHC), a hemp farm and processing facility.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado, with 16 retail locations, for development of commercial scale extraction and product processing, along with derivative product development (edibles, vaporizable products and beverage product mixes). Organigram's partnership with Canada's Smartest Kitchen, a leader in food product development, will expand and develop the Company's edibles R&D program and creation of premium chocolate products. Organigram has also signed a multi-year extraction contract with Valens GroWorks Corp. for Valens to produce extract concentrate for oils and derivative products.

Organigram is well-positioned in the cannabis space with several adult-use recreational product lines. These include:

  • Trailblazer offers a consistent value with a pre-roll, milled format
  • Trailer Park Buds provides niche equity for mainstream users that seek pre-rolls
  • Ankr Organics offers premium, organic pre-roll and oils
  • Edison Cannabis Co. delivers robust, high THC in a whole flower, pre-roll and oil produced from premium sorted flowers
  • Edison Cannabis Co. Reserve offers an ultra-premium, large whole flower that is craft cured and hand trimmed

Experienced Executive Team

  • CEO Gregory Engel has more than 30 years of experience in the pharmaceutical industry with over three years of experience as a CEO for a cannabis company.
  • Jeff Purcell, senior vice president of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods.
  • Tim Emberg, senior vice president of sales and commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and consumer packed good industry.
  • Guillermo Delmonte, president of international operations, brings experience in leading a global cannabis company and worked for 2.5 years as CEO of ICC Labs Inc. in Uruguay.
  • Larry Rogers, vice president of international operations, has held roles for Organigram since 2014 including being a member of the board of directors, chief operating officer and vice president/business development.
  • Paolo DeLuca, chief financial officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities.
  • Ray Gracewood, chief commercial officer, has 15 years of experience in the marketing space and is a previous senior director of sales and marketing for Moosehead Breweries Ltd.
  • Michael Tripp, chief legal officer, worked for private practices at respected business law firms in Moncton and Toronto where he acted on over $3 billion in transactions.

Organigram Holdings Inc. (OTCQX: OGRMF), closed the day's trading session at $6.90, up 7.48%, on 131,513 volume with 461 trades. The average volume for the last 3 months is 299,591 and the stock's 52-week low/high is $2.74/$8.42.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

Canadian cannabis cultivation firm The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) this morning announced its financial and operational results for the first quarter ended March 31, 2019. To view the full press release, visit: http://nnw.fm/xA9pF.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $6.30, up 3.33%, on 163,712 volume with 431 trades. The average volume for the last 3 months is 243,914 and the stock's 52-week low/high is $2.784/$7.565.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Global technology and value-added solutions group Net Element (NASDAQ: NETE) today announced that its Aptito subsidiary's retail and restaurant solutions will be showcased at the 2019 National Restaurant Association Show to be held at Chicago's McCormick Place from May 18 to 21, 2019. To view the full press release, visit: http://nnw.fm/TU8fi.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $0.01463, up 5.25%, on 11,099,794 volume with 244 trades. The average volume for the last 3 months is 10,992,233 and the stock's 52-week low/high is $0.0123/$0.16.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF), a Vancouver-based company developing and designing brands with an emphasis on plant-based health and wellness products, was featured in an article in Vouge titled 'The Hamptons' Favorite Natural Beauty Boutique Lands in Los Angeles' authored by Zoe Ruffner. To view the full article, visit: http://nnw.fm/9Tmy8.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.4338, off by 3.49%, on 19,507 volume with 18 trades. The average volume for the last 3 months is 15,583 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX) is a clinical-stage, gene-therapy company focused on the advancement of its lead drug candidate, Oncoprex(TM) immunogene therapy. Oncoprex is an investigational therapy for non-small cell lung cancer ("NSCLC"). To view the full article, visit: http://nnw.fm/EU8gr.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $2.10, off by 2.33%, on 423,091 volume with 1,381 trades. The average volume for the last 3 months is 36,740 and the stock's 52-week low/high is $0.95/$19.45.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a leading licensed cannabis producer with a diversified portfolio of products and brands, is making significant headway in the cannabis industry and expanding its production capacity. NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company's newsroom at http://nnw.fm/SPRWF. Also today, Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced that the presentations from the Cannastocks2019 Q1 Virtual lnvestor Conference are available for on-demand viewing and among the companies featured is Supreme Cannabis Company.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $3.60, up 34.83%, on 3,388,904 volume with 4,979 trades. The average volume for the last 3 months is 1,322,318 and the stock's 52-week low/high is $1.87/$7.89.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) this morning announced the May 16, 2019 completion of its previously announced acquisition of a Pahrump, Nevada cultivation facility, operated by Wellness Orchards of Nevada LLC ("WON") and Panorama WON LLC ("Panorama") for a purchase price of $13,372,162 (CAD$16,749,970). Per the update, the acquisition expands GGB's Nevada cultivation footprint to two facilities and positions the company to supply its retail operations and enhance its current cannabis wholesale operations. To view the full press release, visit: http://nnw.fm/9oHeO. Also today, the company was pleased to announce that it has raised gross proceeds of US$45.5 million (C$61,233,100) pursuant to a private placement of convertible debt, (the "Debenture Financing") in the form of 15% secured convertible debentures (the "Debentures") at a price of US$1,000 per Debenture and with a conversion price equivalent to C$7.00 per common share. The net proceeds of the Debenture Financing will be used for general corporate and working capital purposes.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $0.09, off by 10.89%, on 9,871 volume with 8 trades. The average volume for the last 3 months is 14,086 and the stock's 52-week low/high is $0.0701/$1.165.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings (OTCQB: GRYN) remains focused on its mission to deliver high-quality and premium-grade cannabis products. The company also aims to expand its portfolio of brands across the United States and then worldwide. An article discussing the company reads, "Green Hygienics recently announced that it has secured licenses for the cultivation and processing of hemp in the state of Michigan (http://nnw.fm/5LKbt). To view the full article, visit: http://nnw.fm/3d3BH.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $1.03, up 3.00%, on 402,228 volume with 452 trades. The average volume for the last 3 months is 222,581 and the stock's 52-week low/high is $0.6574/$3.2929.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) was featured among the stocks covered by the Cannastocks2019 Q1 Virtual lnvestor Conference. The event featured presentations by public companies, providing insight on innovation, consolidation, international expansion and specialization in the fast-growing cannabis industry.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $3.68, up 1.66%, on 17,800 volume with 55 trades. The average volume for the last 3 months is 131,500 and the stock's 52-week low/high is $3.11/$8.00.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech Inc. (OTCQB: ETST) is inviting viewers of its 'As Seen on TV' infomercial aired in the New York market to purchase ETST's industrial-grade, hemp-sourced cannabinoid products online. According to a study by the Brightfield Group, almost two-thirds, or 64.5 percent, of hemp-sourced cannabis is bought online (http://nnw.fm/0knPC).

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.0137, off by 6.36%, on 5,992,366 volume with 158 trades. The average volume for the last 3 months is 10,958,619 and the stock's 52-week low/high is $0.0123/$0.16.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTCQX: PQEFF), an oil and gas industry technology innovator, is developing a surface-oil extraction process that lowers the effects on the environment. To view the full article, visit: http://nnw.fm/PO4Sk.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PHVAF), closed the day's trading session at $0.62, up 28.90%, on 125,014 volume with 67 trades. The average volume for the last 3 months is 21,914 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands, LP (OTC: VPRB), an innovative technology holding company whose assets include patented atomization-related products and technology, recently announced its 2018 financial results, boasting increased revenues and a net operating gain. NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company's newsroom at http://nnw.fm/VPRB.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $6.40, up 6.14%, on 304,270 volume with 551 trades. The average volume for the last 3 months is 264,660 and the stock's 52-week low/high is $2.74/$8.42.

Recent News

chart

Global Consortium, Inc. (OTC: GCGX)

The QualityStocks Daily Newsletter would like to spotlight Global Consortium, Inc. (OTC: GCGX).

Headquartered in Florida, Global Consortium Inc. (OTC: GCGX) is a diversified, cannabis-holding company expanding its reach nationwide. The company's portfolio includes several subsidiaries, partnerships and licensing agreements. Focused on sustainable revenues from operations, GCGX's approach is seed to shelf, thereby providing the company with optimal control of the end-consumer experience. The company believes that the first to market will dominate and is pushing its way to the forefront.

Global Consortium, Inc. (OTC: GCGX) is a diversified cannabis holding company that recently acquired several companies in the cannabis space. Headquartered in Florida, Global Consortium is expanding its reach nationwide with several subsidiaries, partnerships and licensing agreements. Golden Consortium reported over $600,000 in sales in the quarter ended September 30, 2018, and over $2 million in CBD product sales for 2018.

Among Global Consortium’s assets are the following:

  • Infused Edibles has been selling a wide selection of specialty, CBD-infused edible products including gummies, baked goods, fruit and nut mixtures, savory and spicy dried fruits and jerky, and cannabidiol oils for over 13 years. Infused Edibles has received 17 first place awards for its dedicated line of U.S. grown, CBD isolate-infused food products. Infused Edibles operates out of a 6,000 square foot building, servicing 400 stores with dedicated sales reps and eight distributors in 15 states.
  • Infused Oils is a northern California company that produces a premium, 100 percent solvent and pesticide-free cannabis distillate that delivers potency, purity and flavor to medical cannabis patients. Infused Oils uses state-of-the-art CO2 supercritical extraction methods to preserve the delicate cannabinoid and full spectrum terpene profiles of its medical grade oil. Produced from uncommon, boutique cannabis strains that are micro-grown and hand trimmed, Infused Oils creates natural, medicinal cannabis extracts that are strain specific THC and CBD oils of premium quality.
  • America’s first Cannabis Mall, under construction in the Sacramento, California, area, is designed to house cannabis manufacturing, distribution, delivery, retail, testing and cultivation – all under one 64,000 square foot building that showcases various cannabis operations from seed to shelf. The Cannabis Mall will house the largest manufacturing facility of THC and CBD distillates and edibles believed to be operational in the United States. The testing lab at the Cannabis Mall will service outside cannabis vendors as well as all products manufactured there. The distribution space will be leased to a 3rd party with a 50 percent revenue share for Global, while all of Global’s products will be distributed free.

Global Consortium recently entered into a Letter of Intent with MJ Munchies, Inc., a subsidiary of Nightfood Holdings, Inc. (OTC: NGTF), for an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked(TM) mark owned by MJ Munchies. The LOI includes provisions for monthly royalty payments, sales and growth thresholds, and a distribution of proceeds if, and when, the Half-Baked brand is ever sold to a third party.

Global Consortium has also received a weekly order, worth a minimum of $50,000 per week, from the only licensed delivery company servicing the Lake Tahoe, Nevada, area. Over 30 million people live in and visit the Lake Tahoe area, which has no recreational dispensaries. As part of the deal, all of Global’s product lines – Infused Edibles, Indulge Oils and any other products produced – will be offered by the delivery company.

Management

Director, CEO and President Matthew Dwyer has been working in the securities industry since 1986 when he began his career working for Donaldson, Lufkin, and Jenrette. Dwyer went on to hold several securities licenses until 1991 when he ventured off on his own. He has worked in all sectors of the industry from owning an Investors Relations company with one of the first call rooms to working on reverse mergers and debt financing. Dwyer has a well-versed working knowledge of the securities industry, working with both OTC and SEC reporting companies.

Director and incoming President Manuel Losada has over 30 years of healthcare industry experience dedicated to building and achieving profitability and growth. His extensive background includes medical/surgical and device manufacturers, distribution and supply chain, group purchasing organizations, pharmaceuticals and medical product delivery systems. Losada holds a proven track record of successful mergers and acquisitions, business development, and long-range planning for Fortune 500 and multinational companies. He is an energetic professional with exceptional analytical, organizational and people skills, strong personal ethics and integrity. Dwyer is a highly organized team-builder with strong leadership experience and excellent communication skills.

Andrew Moll, Independent Director, has worked as a sales rep for approximately 25 years calling on all types of stores including specialty, resorts, sporting goods, casinos, major department stores and mass merchants. Moll worked in private label production overseas and domestic for NASCAR, Wal-Mart, Coca Cola, Six Flags, Disney, Universal Studios, Sea World, and Hard Rock. In addition, he spent 10 years working with U.S. retailers and apparel brands to secure overseas production with factories in Central and South America as well as China, India, and Pakistan. Moll spent the last 8 years as vice president of sales for a resort athleisure company.

Tom Roland, Chief Operating Officer, is the founder of Indulge Oils. Roland has built a strong reputation in the business over the past 5 years for producing a superior product and delivering on time. He will operate the Cannabis Mall and all manufacturing for both the edibles and distillates departments. Roland is a proven entrepreneur experienced in building profitable companies and has a passion for entrepreneurship, developing innovative approaches to industry challenges, and building vibrant company cultures. He accelerates development and deployment of solutions while maintaining profitable growth. Roland also serves as an advisor to several start-up ventures and continues to empower teams though his provocative leadership.

Marc Adesso, Securities Counsel, of Waller Lansden Dortch & Davis, LLP, is recognized for his work on securities regulation and corporate governance. He has established a national practice counseling issuers, conducting mini-IPOs under Regulation A+ of the JOBS Act, which currently allows companies to raise up to $50 million per year from the general public. Adesso is a key member of the firm’s blockchain and cryptocurrency practice and is lauded as one of the world’s top attorneys in the area of registered offerings of cryptocurrencies such as ICOs. In recognition of his national reputation in the space, as well as being Tennessee’s only veteran cannabis attorney, Adesso chairs the firm’s legalized cannabis practice which counsels clients on the rapidly changing landscape facing the cannabis industry.

Global Consortium, Inc. (OTC: GCGX), closed the day's trading session at $2.10, off by 2.33%, on 423,091 volume with 1,381 trades. The average volume for the last 3 months is 36,740 and the stock's 52-week low/high is $0.95/$19.45.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING) on Thursday announced that it expects to dramatically increase revenues after completion of its largest deal to date, the asset acquisition of Direct Solar. To view the full press release, visit: http://nnw.fm/szQH4.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis' SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint's bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout's subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original "Shark Tank" member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet's secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary's product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation's largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint's chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0145, off by 2.03%, on 4,273,605 volume with 168 trades. The average volume for the last 3 months is 4,136,506 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.